A placebo-controlled trial of pregabalin and amitriptyline for treatment of painful diabetic peripheral neuropathy (PHrMA FDA 1008-040 2007)

Authors
Category Primary study
UnpublishedInformation reported in a systematic review
Year Not known
Loading references information
This reference is based in information provided by a systematic review reporting unpublished data obtained by the authors. This record has been prepared by collaborators of Epistemonikos.

POPULATION:

Diabetic polyneuropathy (n=169/256)

INTERVENTION:

Amitriptyline 75 mg (oral) (max daily dose)

COMPARISON:

Pregabalin
Epistemonikos ID: 847a51bf32596257ac44a7ad303695416b691d6b
First added on: Apr 26, 2017